Business
Add as a preferred source on GoogleRevenue reached $10.6 million, and the company made its results public Nov. 9.
AbCellera Biologics Inc. reported $10.6 million in revenue for the third quarter of 2026, alongside a loss per share that shows the earnings outcome for the quarter.
Basic and diluted earnings per share each came to a loss of $0.13.
AbCellera made its quarterly results public on Nov. 9.
Core operating profit increased 28.6% to ¥43.1 billion. GAAP earnings per share was ¥106.18.
Earnings per share for the period were ¥132.75.
Third-quarter sales reached $890.4 million, while the company reported a $33 million net loss.
